Published in Am J Ind Med on January 01, 1999
Does environmental endotoxin exposure prevent asthma? Thorax (2002) 1.88
Health effects of airborne exposures from concentrated animal feeding operations. Environ Health Perspect (2006) 1.52
Agricultural lung diseases. Environ Health Perspect (2000) 1.33
Animal production and wheeze in the Agricultural Health Study: interactions with atopy, asthma, and smoking. Occup Environ Med (2003) 0.91
Occupational respiratory health of New Zealand horse trainers. Int Arch Occup Environ Health (2006) 0.90
Asthma and atopy in rural children: is farming protective? Clin Med Res (2004) 0.87
Prevalence of respiratory symptoms in sheep breeders. Occup Environ Med (2003) 0.81
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Non-eosinophilic asthma: importance and possible mechanisms. Thorax (2002) 3.53
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg (2003) 3.32
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med (1991) 2.61
The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol (2001) 2.27
Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol (1988) 2.25
Defining and investigating occupational asthma: a consensus approach. Occup Environ Med (2006) 2.22
Prevalence and etiology of asthma. J Allergy Clin Immunol (2000) 2.19
Passive smoking and passive thinking. N Z Med J (1989) 2.17
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
Defining asthma in epidemiological studies. Eur Respir J (1999) 1.88
Does environmental endotoxin exposure prevent asthma? Thorax (2002) 1.88
Occupational asthma in New Zealanders: a population based study. Occup Environ Med (1997) 1.84
House dust mite allergen in pillows. BMJ (1996) 1.83
Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy (2007) 1.81
The ecological fallacy strikes back. J Epidemiol Community Health (2000) 1.79
Latency analysis in occupational epidemiology. Arch Environ Health (1990) 1.77
The role of occupation in the development of chronic obstructive pulmonary disease (COPD). Occup Environ Med (2005) 1.72
Socioeconomic status, asthma and chronic bronchitis in a large community-based study. Eur Respir J (2007) 1.64
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup Environ Med (2004) 1.60
Prevalence and risk factors for self-reported asthma in an adult Indian population: a cross-sectional survey. Int J Tuberc Lung Dis (2013) 1.57
The self reported prevalence of asthma symptoms amongst adult New Zealanders. N Z Med J (1994) 1.57
Risk factors for asthma symptoms in Kawerau children. N Z Med J (1994) 1.56
Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy (2009) 1.55
Asthma in Maori people. N Z Med J (1992) 1.54
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
Accelerated detection and identification of mycobacteria with MGIT 960 and COBAS AMPLICOR systems. J Clin Microbiol (2000) 1.49
Preservatives in nebulizer solutions: risks without benefit. Pharmacotherapy (1998) 1.47
Environmental epidemiology: challenges and opportunities. Environ Health Perspect (2001) 1.47
Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J (2001) 1.46
Colophony: an in vitro model for the induction of sensitization. Clin Exp Allergy (2000) 1.44
Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int J Cancer (1989) 1.43
Respiratory symptoms in insect breeders. Occup Med (Lond) (2011) 1.43
Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy (1999) 1.43
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med (2016) 1.41
Trends in asthma mortality in New Zealand, 1908-1986. Med J Aust (1990) 1.41
Fenoterol and asthma death. N Z Med J (1989) 1.39
Fenoterol, asthma deaths, and asthma severity: confounding or confusion? Thorax (1997) 1.39
Modes of hepatitis B virus transmission in New Zealand. N Z Med J (1989) 1.39
Asthma deaths in New Zealand. BMJ (1992) 1.38
Impact of changes in the death registration process upon Maori mortality statistics. N Z Med J (1999) 1.38
Fenoterol: confounding again. N Z Med J (1989) 1.38
Inappropriate use of inhaled beta agonists in asthma. N Z Med J (1990) 1.37
Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect (1998) 1.32
How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol (2009) 1.30
A simple computer program for generating person-time data in cohort studies involving time-related factors. Am J Epidemiol (1987) 1.27
Measuring the prevalence of bronchial hyper-responsiveness in children. Int J Epidemiol (1995) 1.24
Comparison of a video questionnaire with the IUATLD written questionnaire for measuring asthma prevalence. Clin Exp Allergy (1992) 1.23
Relationship between fetal growth and the development of asthma and atopy in childhood. Thorax (1999) 1.23
Chronic bronchitis, work related respiratory symptoms, and pulmonary function in welders in New Zealand. Occup Environ Med (1998) 1.19
Two year follow up of pulmonary function values among welders in New Zealand. Occup Environ Med (1999) 1.18
Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol (1999) 1.18
Social class inequalities in the decline of coronary heart disease among New Zealand men, 1975-1977 to 1985-1987. Int J Epidemiol (1991) 1.15
Adult-onset acute leukemia and employment in the meat industry: a New Zealand case-control study. Cancer Causes Control (2001) 1.15
Asthma prevalence and deprivation: a small area analysis. J Epidemiol Community Health (1999) 1.13
Lifelong farm exposure may strongly reduce the risk of asthma in adults. Allergy (2007) 1.12
Farm exposure in utero may protect against asthma, hay fever and eczema. Eur Respir J (2008) 1.11
Chronic bronchitis in textile workers. Thorax (1997) 1.11
Prevalence of asthma symptoms among adolescents in the Wellington region, by area and ethnicity. N Z Med J (1993) 1.10
Time-related factors as potential confounders and effect modifiers in studies based on an occupational cohort. Scand J Work Environ Health (1986) 1.10
Mortality in New Zealand workers exposed to phenoxy herbicides and dioxins. Occup Environ Med (2005) 1.10
Short- and medium-term results of totally laparoscopic resection for colorectal liver metastases. Br J Surg (2010) 1.09
Reduced selenium in asthmatic subjects in New Zealand. Thorax (1990) 1.09
Congenital defects and miscarriages among New Zealand 2, 4, 5-T sprayers. Arch Environ Health (1982) 1.07
Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy (2000) 1.07
Occupational risks for brain cancer: a New Zealand Cancer Registry-based study. J Occup Med (1989) 1.05
The magnitude of the effect of smaller family sizes on the increase in the prevalence of asthma and hay fever in the United Kingdom and New Zealand. J Allergy Clin Immunol (1999) 1.05
Seasonal variation in asthma hospitalizations and death rates in New Zealand. Respirology (2000) 1.04
Time trends and occupational differences in cancer of the testis in New Zealand. Cancer (1987) 1.04
Cancer risks in New Zealand farmers. Int J Epidemiol (1989) 1.04
A study of the performance and comparability of the sampling response to cotton dust of work area and personal sampling techniques. Ann Occup Hyg (1992) 1.03
Health expectancy in New Zealand, 1981-1991: social variations and trends in a period of rapid social and economic change. J Epidemiol Community Health (1999) 1.03
Is social class standardisation appropriate in occupational studies? J Epidemiol Community Health (1987) 1.02
Prevalence of respiratory symptoms in migrant children to Italy: the results of SIDRIA-2 study. Allergy (2007) 1.02
The association of early life exposure to antibiotics and the development of asthma, eczema and atopy in a birth cohort: confounding or causality? Clin Exp Allergy (2008) 1.01
Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J (1994) 1.00
Provision and perception of occupational health in small and medium-sized enterprises in Sheffield, UK. Occup Med (Lond) (2001) 1.00
A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. Curr Med Res Opin (1993) 1.00
Chronic bronchitis, shortness of breath, and airway obstruction by occupation in New Zealand. Am J Respir Crit Care Med (1997) 0.99
Fenoterol and asthma mortality. Lancet (1989) 0.99
The relationship between anthropometric measurements at birth: asthma and atopy in childhood. Clin Exp Allergy (1999) 0.99
Prevalence of adult asthma symptoms in relation to climate in New Zealand. Environ Health Perspect (1998) 0.99